Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MPN (Myeloproliferative Neoplasms)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT05115344
What this trial is testing

Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow Tumors

Who this might be right for
Myeloproliferative Neoplasm (MPN)Myelofibrosis，MF
Guizhou Bailing Group Pharmaceutical Co Ltd
Testing effectiveness (Phase 2)Looking for participantsNCT04771130
What this trial is testing

BGB-11417 in Participants With Myeloid Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasm
BeOne Medicines 260
Testing effectiveness (Phase 2)Looking for participantsNCT05817955
What this trial is testing

Clinical Study of Azacitidine Combined With Ruxolitinib in the Treatment of Higher-risk MDS/MPN

Who this might be right for
MDS/MPN
The First Affiliated Hospital with Nanjing Medical University 50
Not applicableStudy completedNCT02252159
What this trial is testing

Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)

Who this might be right for
MPN (Myeloproliferative Neoplasms)
Incyte Corporation 2,544
Testing effectiveness (Phase 2)Looking for participantsNCT06859424
What this trial is testing

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Who this might be right for
AML (Acute Myelogenous Leukemia)Acute Lymphoid Leukemia (ALL)Acute Leukemia (Category)+8 more
Center for International Blood and Marrow Transplant Research 358
Testing effectiveness (Phase 2)Looking for participantsNCT05835466
What this trial is testing

Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

Who this might be right for
Myelofibrosis (PMF)Post Essential Thrombocythemia Myelofibrosis (ET-MF)Post Polycythemia Vera Related Myelofibrosis (PV-MF)
Icahn School of Medicine at Mount Sinai 10
Not applicableLooking for participantsNCT07143669
What this trial is testing

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Who this might be right for
Clonal Mast Cell DiseaseKIT D816V MutationSuspected KITD816V Mutated Clonal Mast Cell Disease
Blueprint Medicines Corporation 750
Testing effectiveness (Phase 2)Study completedNCT05153343
What this trial is testing

Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative

Who this might be right for
Myeloproliferative Neoplasm (MPN)Myelofibrosis，MF
Chengdu Zenitar Biomedical Technology Co., Ltd 31
Early research (Phase 1)WithdrawnNCT02564536
What this trial is testing

Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)

Who this might be right for
Chronic Myelomonocytic LeukemiaJuvenile Myelomonocytic LeukemiaAtypical Chronic Myeloid Leukemia+3 more
Washington University School of Medicine
Testing effectiveness (Phase 2)Study completedNCT03144687
What this trial is testing

Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis

Who this might be right for
MPN (Myeloproliferative Neoplasms)
Incyte Corporation 23
Testing effectiveness (Phase 2)Study completedNCT01712308
What this trial is testing

Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia

Who this might be right for
AnemiaMyelodysplastic/Myeloproliferative NeoplasmMyelofibrosis
M.D. Anderson Cancer Center 56
Not applicableLooking for participantsNCT06480591
What this trial is testing

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Who this might be right for
Myeloproliferative Neoplasm
Wake Forest University Health Sciences 35
Early research (Phase 1)Ended earlyNCT05107856
What this trial is testing

PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies

Who this might be right for
Acute Myeloid LeukemiaB-cell Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+7 more
Prelude Therapeutics Incorporated 21
Testing effectiveness (Phase 2)Ended earlyNCT03123588
What this trial is testing

Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)

Who this might be right for
MPN (Myeloproliferative Neoplasms)
Incyte Corporation 12
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06664970
What this trial is testing

Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor

Who this might be right for
MDS
Peking Union Medical College Hospital 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT05467800
What this trial is testing

Study of Canakinumab in Patients With Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost-essential Thrombocythemia MyelofibrosisET-MF+2 more
John Mascarenhas 14
Testing effectiveness (Phase 2)Study completedNCT02076191
What this trial is testing

Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML

Who this might be right for
Myeloproliferative Neoplasms
John Mascarenhas 49
Not applicableStudy completedNCT04385160
What this trial is testing

Myeloproliferative Neoplasms (MPN) and COVID-19

Who this might be right for
Myeloproliferative NeoplasmCOVID
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 552
Testing effectiveness (Phase 2)Ended earlyNCT02587598
What this trial is testing

Study of INCB053914 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors
Incyte Corporation 97
Not applicableActive Not RecruitingNCT03618485
What this trial is testing

Registry of Patients With MPNs in Taiwan

Who this might be right for
Myeloproliferative Neoplasms
Chang Gung Memorial Hospital 500
Next Page